Obeticholic acid attenuates complete freund’s adjuvant-induced arthritis in rats through FXR-mediated modulation of TGF-β/TAK1/MKK3/p38 MAPK signaling, inflammation, and oxidative stress

Mohamed Magdy Senna, Nesma A. Shiha, Hala F. Zaki, Laila A. A. Ramadan, Aya M. Mustafa · 2026

Read Obeticholic acid attenuates complete freund’s adjuvant-induced arthritis in rats through FXR-mediated modulation of TGF-β/TAK1/MKK3/p38 MAPK signaling, inflammation, and oxidative stress by Mohamed Magdy Senna, Nesma A. Shiha, Hala F. Zaki, Laila A. A. Ramadan, Aya M. Mustafa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675349.txt.

Description

Senna and co-authors test obeticholic acid against arthritis in rats. Rheumatoid arthritis is a chronic autoimmune disease marked by joint inflammation, oxidative stress, and slow destruction of cartilage and bone. Activation of the farnesoid X receptor has emerged as a possible brake on immune inflammation.

Obeticholic acid switches that receptor on. In rats with adjuvant-induced arthritis, the drug eased disease through FXR-driven control of a TGF-beta signaling chain in joint tissue. That chain runs through TAK1, MKK3, and p38 MAPK proteins. The treatment also cut inflammation and oxidative stress in the joints of the treated rats.

Catalog record

CREATORMohamed Magdy Senna, Nesma A. Shiha, Hala F. Zaki, Laila A. A. Ramadan, Aya M. Mustafa
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13675349

Browse the full library · About the Tower of Babel